Danny Wells

Danny Wells is a highly accomplished individual with a background in mathematics and data science. Currently serving as the Founder and CTO of Santa Ana Bio, Inc, Danny is dedicated to advancing precision immunology to tackle autoimmune diseases at the cellular level. With significant experience in genomic immunology and data integration at Immunai, and as a former Principal Scientist at Parker Institute for Cancer Immunotherapy, Danny has a strong foundation in research and scientific leadership. Their educational achievements include a BA in Mathematics from Carleton College, a PhD in Applied Mathematics from Northwestern University, and a Postdoc in Evolutionary Cellular Biology from the University of California, Berkeley.